Amyloid fibrils in neurodegenerative diseases: villains or heroes?

Future Med Chem. 2013 Oct;5(16):1903-6. doi: 10.4155/fmc.13.138.

Author

Xavier Fernàndez-Busquets¹

Affiliation

¹ Institute for Bioengineering of Catalonia (IBEC), Baldiri Reixac 10-12, Barcelona E08028, Spain Barcelona Centre for International Health Research (CRESIB, Hospital Clínic-Universitat de Barcelona), Rosselló 149-153, Barcelona E08036, Spain and Nanoscience & Nanotechnology Institute (IN2UB), University of Barcelona, Martí i Franquès 1, Barcelona E08028, Spain. xfernandez_busquets@ub.edu.

PMID: 24175741
DOI: 10.4155/fmc.13.138

No abstract available

Publication types

Editorial
Research Support, Non-U.S. Gov't

MeSH terms

Amyloid / antagonists & inhibitors
Amyloid / metabolism*
Amyloid beta-Peptides / antagonists & inhibitors
Amyloid beta-Peptides / metabolism
Glycosaminoglycans / metabolism
Humans
Neurodegenerative Diseases / metabolism*
Neurodegenerative Diseases / pathology

Substances

Amyloid
Amyloid beta-Peptides
Glycosaminoglycans